Diabetes resulted in significantly enhanced total and phosphorylated forms of ErbB3 and ErbB4 receptors that could be significantly reversed by chronic in vivo and, to a lesser extent, by acute ex vivo treatment with Ang-(1–7) in the diabetic mesenteric vascular bed (p<0.05; Fig 9). The gene discussed is ERBB3; the disease is diabetes mellitus.